Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas A. Zalewski currently holds 75,000 shares of Aquestive Therapeutics, Inc. (AQST), valued at approximately $0. This represents their equity stake as Chief Legal Officer.
Based on SEC Form 4 filings, Thomas A. Zalewski has been a net neutral trader of AQST stock. They have purchased $0 and sold $0 worth of shares.
Thomas A. Zalewski's most recent insider trade was on May 18, 2026, when they sold 75,000 shares at $0.00 per share.
Thomas A. Zalewski serves as Chief Legal Officer at Aquestive Therapeutics, Inc. (AQST). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Thomas A. Zalewski holds the position of Chief Legal Officer at Aquestive Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Thomas A. Zalewski has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Thomas A. Zalewski was on May 18, 2026, when they purchased $0 worth of AQST shares. This transaction involved 75,000 shares at N/A per share.
Thomas A. Zalewski currently owns 75,000 shares of Aquestive Therapeutics, Inc. (AQST), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas A. Zalewski's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas A. Zalewski has 2 Form 4 filings on record as an insider at Aquestive Therapeutics, Inc..
Set alerts for Thomas A. Zalewski and 40,000+ other insiders.